Long

CGC prepping for generous PRICE GROWTH!

Updated

(Canopy Growth Corp)

CGC is lowkey trying to cook something based on the recent price action this past 6 weeks. Net positive volume / accumulation has almost doubled this past few days, from 35M to 61m and continuing to rise.

Last QTR earnings (August 9, 2023) has aided the significant price recovery - propelling earnings to green territory to 60.3% and revenues to 20%, first green output in the last 5 quarters (15 months).

RR ratio on this one looks attractive.

Spotted at 0.55

TAYOR.
*Safeguard funds always.
Factor the muted financial standing of this stock before trading.

Trade active

Congrats holders +24%, more to go

Trade active

CGC, new weekly higher low base spotted.

Expect some more than average rise from here on.

Spotted at 0.550

TAYOR.

Trade active

(Canopy Growth Corp)

CGC will live up to its name soon.

initial target set at X3.

Long term price shift.

TAYOR
---------

Reference news:

Canopy Growth Corp. said Friday that it has completed the sale of BioSteel Canada and BioSteel Manufacturing LLC for $30.4 million.

The sale was completed pursuant to the proceedings under the Companies' Creditors Arrangement Act. BioSteel Canada was sold to the Coachwood Group while a different third party acquired BioSteel Manufacturing.

Canopy Growth plans to use a portion of the proceeds to repay debt, which would further reduce interest expense.

"With the completion of these two sale transactions, we have completed another critical action to focus Canopy Growth's business on our core cannabis operations and can now realize the proceeds of sale to further improve the company's balance sheet," Canopy CFO Judy Hong said.

The company at last look rose 4% in early Friday trading.

Trade active

Preppin for x2 soon.

New base has been cemented. Ready for 'high' flight.

TAYOR.

Trade active

We're up almost 300% now.

From 4.8 to 14.88

Congrats holders.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.